As we get older, our bodies continuously lose muscle mass. This natural process, which begins at around the age of thirty, can be mitigated by regular exercise, but cannot be stopped. In many cases, this can also lead to excessive muscle loss (sarcopenia), which manifests as marked weakness and impaired organ function. Swiss researchers have now discovered – at least in a mouse model – how muscle loss can be slowed down by combining two further strategies. Both a reduced calorie intake and the immunosuppressant rapamycin (sirolimus) have already been promoted as anti-ageing measures. When these measures are combined, they are even more effective, according to the scientists who have now tested this. The mice’s muscle function improved sustainably under the new combination therapy, and the rodents also proved to be significantly more agile than their counterparts who had received only one of these therapies. It was assumed that moderate fasting and rapamycin inhibit the mTORC1 protein complex via different mechanisms, as increased activity of this complex accelerates ageing processes in the body. However, the researchers now believe this does not appear to be the case. It appears that a low-calorie diet combined with the drug produces additional effects. Whether this combination, combined with physical activity, could benefit elderly people suffering from sarcopenia, however, remains to be investigated. Reference: University of Basel Distinct and additive effects of calorie restriction and rapamycin in ageing skeletal muscle, Nature Communications 2022; https://www.nature.com/articles/s41467-022-29714-6
A combined strategy to combat age-related muscle loss